Novacept Overview

  • Year Founded
  • 1995

Year Founded

  • Status
  • Acquired/​Merged

  • Latest Deal Type
  • M&A

  • Latest Deal Amount
  • $325M

Novacept General Information

Description

Developer of medicine meant for the treatment of menstrual bleeding. The company designs, develop, manufacture and market innovative therapeutic medical devices to improve the quality and cost-effectiveness of women's healthcare.

Contact Information

Website
www.novacept.com
Ownership Status
Acquired/Merged
Financing Status
Formerly VC-backed
Corporate Office
  • 1047 Elwell Court
  • Palo Alto, CA 94303
  • United States
+1 (650) 000-0000
Primary Industry
Therapeutic Devices
Acquirer
Cytyc
Vertical(s)
Manufacturing
Corporate Office
  • 1047 Elwell Court
  • Palo Alto, CA 94303
  • United States
+1 (650) 000-0000

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Novacept Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
6. Merger/Acquisition 26-Mar-2004 $325M 0000 00000 Completed Clinical Trials - General
5. IPO 24-Mar-2004 000.00 Cancelled Clinical Trials - General
4. Later Stage VC 26-Dec-2003 00.000 0000 Completed Clinical Trials - General
3. Later Stage VC (Series H) 16-May-2002 0000 000.00 Completed Generating Revenue
2. Later Stage VC $25.4M $40.7M Completed Generating Revenue
1. Later Stage VC (Series G) 02-Apr-2001 $15.3M $15.3M Completed Generating Revenue
To view Novacept’s complete valuation and funding history, request access »

Novacept Patents

  • 21

    Total Documents Applications and Grants

  • 000

    Total Patents Families

  • 5

    Granted

  • 000

    Pending

  • 000

    Expiring in next 12 mo

Novacept Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
AU-2002239929-A1 Apparatus and method for treating venous reflux Inactive 16-Jan-2001 00000000000
AU-2000276035-A1 Flat-bed knitting machine and method of knitting Inactive 14-Feb-2000 000000000
EP-1255886-A1 Flat-bed knitting machine and method of knitting Active 14-Feb-2000 000000000
DE-60018478-T2 Flat knitting machine and knitting process Inactive 14-Feb-2000 000000000
DE-60018478-D1 Flat knitting machine and knitting process Inactive 14-Feb-2000 D04B15/90
To view Novacept’s complete patent history, request access »

Novacept Executive Team (12)

Name Title Board Seat
Michael Kaplan Director
Ross Jaffe MD Director
Rodney Perkins MD Chairman
You’re viewing 3 of 12 executive team members. Get the full list »

Novacept Board Members (2)

Name Representing Role Since
Rodney Perkins MD Self Chairman 000 0000
You’re viewing 1 of 2 board members. Get the full list »

Novacept Former Investors (14)

Investor Name Investor Type Holding Investor Since Participating Rounds
Band of Angels Angel Group Minority 000 0000 000000 0
Brentwood Venture Capital Venture Capital Minority 000 0000 000000 0
Fitch Group Corporation Minority 000 0000 000000 0
ITX (US) Corporation Minority 000 0000 000000 0
Johnson & Johnson Innovation - JJDC Corporate Venture Capital Minority 000 0000 000000 0
You’re viewing 5 of 14 investors. Get the full list »

Ready to get started?

Request a free trial

Novacept FAQs

  • When was Novacept founded?

    Novacept was founded in 1995.

  • Where is Novacept headquartered?

    Novacept is headquartered in Palo Alto, CA.

  • What industry is Novacept in?

    Novacept’s primary industry is Therapeutic Devices.

  • Is Novacept a private or public company?

    Novacept is a Private company.

  • What is the current valuation of Novacept?

    The current valuation of Novacept is 00000.

  • What is Novacept’s current revenue?

    The current revenue for Novacept is 00000.

  • How much funding has Novacept raised over time?

    Novacept has raised $73M.

  • Who are Novacept’s investors?

    Band of Angels, Brentwood Venture Capital, Fitch Group, ITX (US), and Johnson & Johnson Innovation - JJDC are 5 of 14 investors who have invested in Novacept.

  • When was Novacept acquired?

    Novacept was acquired on 26-Mar-2004.

  • Who acquired Novacept?

    Novacept was acquired by Cytyc.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »